Table 1.
Value | Edwards Series | Swaroop Series | Seddon Series | AREDS Series† | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients with Geographic Atrophy |
Patients with Exudative AMD |
Controls | Patients with Geographic Atrophy |
Patients with Exudative AMD |
Controls | Patients with Geographic Atrophy |
Patients with Exudative AMD |
Controls | Patients with Geographic Atrophy |
Patients with Exudative AMD |
Controls | |
No. of participants | 89 | 178 | 222 | 279 | 377 | 317 | 218 | 646 | 479 | 184 | 247 | 171 |
Genotype — no. (%) | ||||||||||||
CC | 42 (47) | 73 (41) | 124 (56) | 135 (48) | 171 (45) | 158 (50) | 113 (52) | 305 (47) | 235 (49) | 86 (47) | 117 (47) | 81 (47) |
CT | 41 (46) | 88 (49) | 81 (36) | 120 (43) | 171 (45) | 124 (39) | 78 (36) | 304 (47) | 210 (44) | 82 (45) | 108 (44) | 78 (46) |
TT | 6 (7) | 17 (10) | 17 (8) | 24 (9) | 35 (9) | 35 (11) | 27 (12) | 37 (6) | 34 (7) | 16 (9) | 22 (9) | 12 (7) |
Frequency of minor T allele | 0.30 | 0.34 | 0.26 | 0.30 | 0.32 | 0.31 | 0.30 | 0.29 | 0.29 | 0.31 | 0.31 | 0.30 |
P value | ||||||||||||
Allele | 0.33 | 0.01 | 0.86 | 0.58 | 0.68 | 0.94 | 0.74 | 0.76 | ||||
Additive genotype | 0.33 | 0.01 | 0.86 | 0.59 | 0.63 | 0.90 | 0.73 | 0.77 |
The TaqMan genotyping platform was used for the Edwards and Swaroop series, the Affymetrix 6.0 genotyping platform for the Seddon series, and the Illumina Human-1 genotyping platform for the Age-Related Eye Disease Study (AREDS). AMD denotes age-related macular degeneration. P values are for comparisons with controls with the use of an additive model of genotype effect on the risk of AMD.
Data are from the National Institutes of Health Genotype and Phenotype database (dbGaP) (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000001.v2.p1; accession number, phs000001.v2.p1).